After figuring out how to grow recombinant bacteria on an industrial scale and how to harvest the insulin they produce, it was time to bring the recombinant insulin to the market. In 1982 Food and ...

As luck would have it, new developments in biotechnology provided an alternate source for insulin. Recombinant DNA, a lab technique developed in the early 1970s, allowed pharmaceutical manufacturers ...

Insulin human (recombinant) is under clinical development by Elgan Pharma and currently in Phase III for Malabsorption Syndrome.

For example, recombinant insulin for diabetes now accounts for more than 70% of the worldwide human insulin market. Other successful recombinant products include erythropoietin, interferon alpha ...

Antiobesity drugs are amazing people by how fast they melt off pounds. But it's no surprise to Richard DiMarchi.

Brazilian President Luiz Inácio Lula da Silva Friday participated in the city of Nova Lima, state of Minas Gerais, in the opening of the Biomm recombinant human insulin-producing plant.

Despite entering its maturation phase, the recombinant protein sector will continue to drive the growth of medical biotechnology over the next six years. You have full access to this article via ...

The history of biopharmaceuticals dates back to the early 1980s, with the approval of the first recombinant human insulin (Humulin) in 1982. Since then, the field has experienced rapid growth and ...

Sydney-based biotech company All G affirmed the GRAS status of its recombinant bovine lactoferrin ... Biotech was a “solution for insulin,” which initially required slaughtering thousands ...